Delivery Order SPE2DB24D2105-SPE2DB25FAQGB
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,750.23 to AmerisourceBergen Drug Corp for the supply of Clobazam 10 mg tablets (100 count) on August 6, 2025, with completion scheduled for August 7, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and...
- The Defense Logistics Agency awarded a delivery order valued at $1,555.93 to AmerisourceBergen Drug Corp for the supply of Clobazam 10 mg tablets (100-count packages) on September 24, 2025, with an ultimate completion date of September 25, 2025. This non-competitive delivery order utilizes firm fixed price pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $37,552.54 by the Defense Logistics Agency (DLA) on July 14, 2025, with an ultimate completion date of July 15, 2025. The contract calls for the delivery of Clobazam 10 mg tablets in quantities of 100 units. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Clobazam 10 mg tablets (100-count) with a ceiling value of $3,414.22. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by August 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's substantial pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $2,637.91 to AmerisourceBergen Drug Corp for the supply of Clobazam 10 mg tablets (100 count) under a firm fixed-price contract type. The delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 3, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in...
- The Defense Logistics Agency awarded a $1,555.93 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Clobazam 10 mg tablets (100 count). This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be delivered to the company's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $1,893.33 to AmerisourceBergen Drug Corp for the supply of Clobazam 10 mg tablets (100-count packages) with an ultimate completion date of September 17, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating this was a competitively awarded procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,180.96 delivery order for 100 tablets of Clobazam 10 mg, with an ultimate completion date of August 1, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving critical federal medical procurement needs, particularly for military and veteran healthcare systems. The award...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Clobazam 10 mg tablets (100-count) valued at $2,214.14. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and requires completion by September 11, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a leading pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Clobazam 10 mg tablets (100 count) with a ceiling value of $1,015.46 under a firm fixed price contract. This award represents a non-set-aside competitive procurement processed as a delivery order, with an ultimate completion date of September 25, 2025. AmerisourceBergen's Corporate Office, headquartered in Conshohocken, Pennsylvania, will serve as the place of performance...
- SPE2DB24D2105Indefinite Delivery Contract
- SPE2DB24D2105-SPE2DB25FAQGBDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,724.61 to AmerisourceBergen Drug Corp for Clobazam 10 mg tablets (100-count units) on September 22, 2025, with completion expected by September 23, 2025. This is a firm fixed price contract with no set-aside designation, indicating competitive award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to military and veteran healthcare systems globally. The contract supports critical defense health operations across multiple therapeutic domains and represents AmerisourceBergen's established capability to fulfill federal pharmaceutical procurement requirements through open competition. The DLA is currently planning next-generation Pharmaceutical Prime Vendor Global Program contracts with multiple regional awards, positioning AmerisourceBergen as a key strategic vendor for defense health procurement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 9/22/25 |